Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.
Najafi-Fard S, Petruccioli E, Farroni C, Petrone L, Vanini V, Cuzzi G, Salmi A, Altera AMG, Navarra A, Alonzi T, Nicastri E, Palmieri F, Gualano G, Carlini V, Noonan DM, Albini A, Goletti D. Najafi-Fard S, et al. Among authors: navarra a. Front Immunol. 2022 Sep 6;13:984098. doi: 10.3389/fimmu.2022.984098. eCollection 2022. Front Immunol. 2022. PMID: 36148228 Free PMC article.
High urine IP-10 levels associate with chronic HCV infection.
Petrone L, Chiacchio T, Vanini V, Petruccioli E, Cuzzi G, Di Giacomo C, Pucci L, Montalbano M, Lionetti R, Testa A, Lapa D, Navarra A, Visco-Comandini U, Goletti D. Petrone L, et al. Among authors: navarra a. J Infect. 2014 Jun;68(6):591-600. doi: 10.1016/j.jinf.2014.02.008. Epub 2014 Feb 26. J Infect. 2014. PMID: 24582930
Use of several immunological markers to model the probability of active tuberculosis.
Petruccioli E, Navarra A, Petrone L, Vanini V, Cuzzi G, Gualano G, Palmieri F, Girardi E, Goletti D. Petruccioli E, et al. Among authors: navarra a. Diagn Microbiol Infect Dis. 2016 Oct;86(2):169-71. doi: 10.1016/j.diagmicrobio.2016.06.007. Epub 2016 Jun 14. Diagn Microbiol Infect Dis. 2016. PMID: 27431433
Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study.
Sane Schepisi M, Navarra A, Altet Gomez MN, Dudnyk A, Dyrhol-Riise AM, Esteban J, Giorgetti PF, Gualano G, Guglielmetti L, Heyckendorf J, Kaluzhenina A, Lange B, Lange C, Manika K, Miah J, Nanovic Z, Pontali E, Prego MR, Solovic I, Tiberi S, Palmieri F, Girardi E. Sane Schepisi M, et al. Among authors: navarra a. Open Forum Infect Dis. 2018 Dec 19;6(1):ofy337. doi: 10.1093/ofid/ofy337. eCollection 2019 Jan. Open Forum Infect Dis. 2018. PMID: 30697572 Free PMC article.
Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
Gualano G, Mencarini P, Musso M, Mosti S, Santangelo L, Murachelli S, Cannas A, Di Caro A, Navarra A, Goletti D, Girardi E, Palmieri F. Gualano G, et al. Among authors: navarra a. PLoS One. 2019 Feb 28;14(2):e0212948. doi: 10.1371/journal.pone.0212948. eCollection 2019. PLoS One. 2019. PMID: 30817779 Free PMC article.
Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases.
Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Massafra U, Baldi G, Navarra A, Scrivo R, Mastroianni C, Sauzullo I, Esposito C, Palmieri F, Cantini F, Goletti D. Chiacchio T, et al. Among authors: navarra a. J Infect. 2019 Jul;79(1):15-23. doi: 10.1016/j.jinf.2019.04.010. Epub 2019 Apr 11. J Infect. 2019. PMID: 30981891
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases.
Goletti D, Navarra A, Petruccioli E, Cimaglia C, Compagno M, Cuzzi G, De Carli G, Fondaco L, Franzetti F, Giannetti A, Gori A, Lapadula G, Lichtner M, Mastroianni CM, Mazzotta V, Orchi N, Pavone P, Piacentini D, Pirriatore V, Pontali E, Sarmati L, Spolti A, Tacconelli E, Galli M, Antinori A, Calcagno A, Girardi E. Goletti D, et al. Among authors: navarra a. Int J Infect Dis. 2020 Mar;92:62-68. doi: 10.1016/j.ijid.2019.12.031. Epub 2019 Dec 27. Int J Infect Dis. 2020. PMID: 31887456 Free article.
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.
Cantini F, Niccoli L, Nannini C, Matarrese D, Natale MED, Lotti P, Aquilini D, Landini G, Cimolato B, Pietro MAD, Trezzi M, Stobbione P, Frausini G, Navarra A, Nicastri E, Sotgiu G, Goletti D. Cantini F, et al. Among authors: navarra a. J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.06.052. Epub 2020 Jun 24. J Infect. 2020. PMID: 32592703 Free PMC article.
119 results